Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
| Status: | Completed |
|---|---|
| Conditions: | Lung Cancer, Colorectal Cancer, Ovarian Cancer, Cervical Cancer, Cancer, Cancer, Gastrointestinal, Endometrial Cancer |
| Therapuetic Areas: | Gastroenterology, Oncology |
| Healthy: | No |
| Age Range: | 19 - Any |
| Updated: | 11/9/2018 |
| Start Date: | December 14, 2010 |
| End Date: | October 29, 2018 |
The purpose of this study is to determine whether narrowband imaging (NBI) makes it easier
for a surgeon to see cancer.
NBI is a kind of light. Normally, white light is used during surgery. White light uses many
wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This
makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels
than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors.
In this study the surgeon will look with both normal white light and NBI. This way a
comparison can be made to determine which is superior.
Improved identification of tumors allows doctors and patients to make informed decisions
about whether treatment is needed after surgery. It also provides additional information to
determine which treatments may be best.
for a surgeon to see cancer.
NBI is a kind of light. Normally, white light is used during surgery. White light uses many
wavelengths of light. NBI only uses two wavelengths which highlight the blood vessels. This
makes it easier for the surgeon to see blood vessels. Tumors often have more blood vessels
than normal tissue. As a result, NBI may make it easier for the surgeon to see small tumors.
In this study the surgeon will look with both normal white light and NBI. This way a
comparison can be made to determine which is superior.
Improved identification of tumors allows doctors and patients to make informed decisions
about whether treatment is needed after surgery. It also provides additional information to
determine which treatments may be best.
Inclusion Criteria:
- Patients must meet one (or more) of the following criteria:
- Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma
(all stage, grade and histology)
- Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)
- Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)
- Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)
- Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)
- Gastrointestinal carcinoma (all histology, stage and grade)
- Pancreatic carcinoma (all histology, stage and grade)
- Lung cancer (all histology, stage and grade)
- Esophageal carcinoma (all histology, stage and grade)
- Suspected or pathologically confirmed metastatic disease to the lung (all disease
primaries)
- Suspected or pathologically confirmed malignant pleural effusion (all disease
primaries)
Patients must meet all of the following criteria:
- Planned thorascopic robotic or laparoscopic surgical approach
- >18 years old
- Not pregnant
- Able to give consent Participation in other research protocols does not exclude a
patient from participation in this study.
Exclusion Criteria:
We found this trial at
1
site
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials
